Bank Execs Walk the Plank

Recs

2

You probably could have seen this coming. Last year, Chuck Prince at Citigroup (NYSE: C) and Stan O'Neal from Merrill Lynch (NYSE: MER) got the axe. Now, after a brutal bout of losses and writedowns, another round of bank-exec demotions is shaking the financial world.

Steeeeerike 3!
Washington Mutual (NYSE: WM) CEO Kerry Killinger has been stripped of his chairman title, in what appears to be a move by the struggling Seattle-based bank to establish order in its corporate governance. He'll be replaced by Stephen Frank, who's sat on WaMu's board for more than a decade.

It's been a tumultuous few months for WaMu, which has been hammered hard over its heavy exposure to the California and Florida housing markets. Back in March, Killinger came under fire from shareholders after disclosing that some executives' bonuses would be calculated as if parts of the real estate debacle -- the same one that's shoved shares 80% lower in the past year -- essentially never happened. That plan was eventually scrapped, but only in time for shareholders to eat a $7 billion dilution and learn that management had rebuffed a sweet offer from JPMorgan Chase (NYSE: JPM). Shoulda, woulda, coulda.

On the other side of the country, Wachovia (NYSE: WB) CEO Ken Thompson was ousted by the company's board of directors after eight years at the helm. After orchestrating the 2006 purchase of lender Golden West Financial near the peak of the housing bubble, Thompson was left looking about as susceptible to the market's hysteria as any of the investors who believed real estate would march higher until the end of time. Shareholders were left floundering with a nearly $400 million first-quarter loss.

New face, same company
As Peter Lynch once said, "Go for a business that any idiot can run -- because sooner or later, any idiot probably is going to run it." Bank executives enjoyed a multiyear run-up that rewarded ridiculous behavior, provided those actions squeezed out short-term profits. While you should have little pity for the departed executives, the past few years have been a double-edged sword for them. Had they done the "appropriate" thing during the real estate run-up and stuck to time-tested, conservative lending practices, they would have likely been fired for underperforming their gung-ho peers. When quarterly results become the end-all performance metric, there's little room for leaders to venture outside the herd.  

For related Foolishness: 

Closed for 15 months – opening 10 days only! Get notified ahead of time as our expert portfolio manager invests $1 MILLION in the best opportunities from across The Motley Fool’s premium investment services. This is the first open since August 2008, by invitation only. Enter email below.

Fool contributor Morgan Housel doesn't own shares in any of the companies mentioned in this article. He appreciates your questions, comments, and complaints. JPMorgan Chase is an Income Investor recommendation. The Fool has a disclosure policy.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 656287, ~/Articles/ArticleHandler.aspx, 11/10/2009 7:07:05 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
Health-Care Reform: A Tale of Two Chambers

Related Tickers

11/9/2009 4:00 PM
C $4.19 Up +0.13 +3.20%
Citigroup, Inc. CAPS Rating: **
JPM $44.35 Up +0.87 +2.00%
JPMorgan Chase & C… CAPS Rating: ***
MER $11.64 Down +0.00 +0.00%
Merrill Lynch & Co… CAPS Rating: *
WB $5.54 Down +0.00 +0.00%
Wachovia Corp CAPS Rating: **
WAMUQ.PK $0.13 Down +0.00 -2.33%
Washington Mutual,… CAPS Rating: **

Community: Investing Wiki

Term Of The Hour

Biotechnology: Biotechnology uses biological processes to solve problems in such areas as health and medicine, agriculture and manufacturing.

Want to learn more or edit this definition?
Click here to read more!